~~<i id='008A7944F1'><strike id='008A7944F1'><tt id='008A7944F1'><pre id='008A7944F1'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

Wikipedia

knowledge

author：comprehensive 2025-09-02 09:56:58 - browse：1786

Calling Bullshit course University of Washington — Screenshot via callingbullshit.org

Tired of alternative facts, fake news, and breathless hyperbole, two professors at the University of Washington are trying to strike a blow for science.

Their weapon? A new course: “Calling Bullshit In the Age of Big Data.”

The class website and colorful syllabus went online last month and almost instantly went viral.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Websites selling Wegovy, Zepbound ingredients targeted by FDA

knowledge

leisure time

focus

hotspot

knowledge

hotspot

LISELOTTESABROE/AFP/GettyImagesApillbeingdevelopedbyDanishdrugmakerNovoNordiskmayleadtogreaterweight

WSS

Amylyx and the next ALS drug test, plus a chat with CRISPR's CEO

Readout Newsletter: Replicate, Biogen's Leqembi, and Humira

With psoriasis trial ahead, Alumis raises $259 million

Sen. Paul opposes bill to ban Chinese biotechs

Just how do doctors, lawmakers, and the public define abortion?

Just how do doctors, lawmakers, and the public define abortion?

Wikipedia

knowledge

knowledge

BioMarin wins approval for gene therapy to treat hemophilia A

Latigo launches with $135 million for Vertex

Heart attack and stroke risk calculators need revising

The problem with charging patients to message their doctors

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

First medicine developed to treat MASH expected to be approved soon

Moonlake's readout produced a cash windfall. Risks remain

The drug industry has found itself all alone in Washington

What does generative AI mean for health care? We asked experts

AMAs digital advisors table RPM coding reform proposal, again

leisure time

Too many hospitalized Covid

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

A deep dive into Applied Therapeutics’ data, and questions on Cassava

Amylyx and the next ALS drug test, plus a chat with CRISPR's CEO

Readout Newsletter: Replicate, Biogen's Leqembi, and Humira

IVF, abortion rights issues kick off Biden’s State of the Union

focus

hotspot

knowledge

hotspot